These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20204551)

  • 21. Technetium-99m -- new production and processing strategies to provide adequate levels for SPECT imaging.
    Osso JA; Catanoso MF; Barrio G; Brambilla TP; Teodoro R; Dias CR; Suzuki KN
    Curr Radiopharm; 2012 Jul; 5(3):178-86. PubMed ID: 22642387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Situation of supply and boom of PET imaging: what is the future for technetium-99m in nuclear medicine?].
    Maia S; Ayachi Hatit N; Paycha F
    Ann Pharm Fr; 2011 May; 69(3):155-64. PubMed ID: 21570540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative production methods to face global molybdenum-99 supply shortage.
    Lyra M; Charalambatou P; Roussou E; Fytros S; Baka I
    Hell J Nucl Med; 2011; 14(1):49-55. PubMed ID: 21512666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)Tc.
    Cutler CS; Schwarz SW
    J Nucl Med; 2014 Jul; 55(7):1208-13. PubMed ID: 24854794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
    Chakravarty R; Ram R; Dash A; Pillai MR
    Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of technetium-99m wastage in selected private sector nuclear medicine imaging departments.
    Mathurine G; Bresser P; Teixeira N
    Nucl Med Commun; 2013 Dec; 34(12):1233-6. PubMed ID: 24089081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breaking America's dependence on imported molybdenum.
    Einstein AJ
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):369-71. PubMed ID: 19356583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming the 99mTc shortage: are options being overlooked?
    Pillai MR; Knapp FF
    J Nucl Med; 2011 Feb; 52(2):15N-16N, 28N. PubMed ID: 21270452
    [No Abstract]   [Full Text] [Related]  

  • 30. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
    Jalilian AR; Beiki D; Hassanzadeh-Rad A; Eftekhari A; Geramifar P; Eftekhari M
    Semin Nucl Med; 2016 Jul; 46(4):340-58. PubMed ID: 27237443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of Residual Radioactivity Rate of
    Nakamura Y; Kangai Y; Sato S; Shibata S; Abe T; Mimura H; Inubushi M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Aug; 79(8):802-809. PubMed ID: 37357400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeability of gloves used in nuclear medicine departments to [(99m)Tc]-pertechnetate and [(18)F]-fluorodeoxyglucose: radiation protection considerations.
    Ridone S; Matheoud R; Valzano S; Di Martino R; Vigna L; Brambilla M
    Phys Med; 2013 Sep; 29(5):545-8. PubMed ID: 23419926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nuclear medicine: the next world shortage of technetium 99m].
    Nau JY
    Rev Med Suisse; 2014 Mar; 10(420):570-1. PubMed ID: 24701678
    [No Abstract]   [Full Text] [Related]  

  • 34. In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.
    Martini P; Boschi A; Cicoria G; Zagni F; Corazza A; Uccelli L; Pasquali M; Pupillo G; Marengo M; Loriggiola M; Skliarova H; Mou L; Cisternino S; Carturan S; Melendez-Alafort L; Uzunov NM; Bello M; Alvarez CR; Esposito J; Duatti A
    Appl Radiat Isot; 2018 Sep; 139():325-331. PubMed ID: 29936404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Efficacy of Sodium [99mTc] Pertechnetate from Low Specific Activity 99Mo/99mTc Autosolex Generator in Hospital Radiopharmacy Centre.
    Mitra A; Chattopadhyay S; Chandak A; Lad S; Barua L; De A; Kumar U; Chinagandham R; Upadhye T; Koundal K; Banerjee S; Rajan R
    Nucl Med Rev Cent East Eur; 2020; 23(1):1-14. PubMed ID: 32779168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of 99Mo measurement in 99mTc eluate samples using a scintillation detection system.
    Dantas AL; Ribeiro BS; Souza RS; Lucena EA; Dantas BM
    Health Phys; 2010 Oct; 99(4):453-6. PubMed ID: 20838085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiopharmaceutical Options for the Ventilation Part of Ventilation-Perfusion Scintigraphy Performed for the Indication of Pulmonary Embolism: US Practice Survey.
    Opanowski A; Gross LJ; Tulchinsky M
    Clin Nucl Med; 2015 Jul; 40(7):553-8. PubMed ID: 25899592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of internal exposure to 99Mo in nuclear medicine patients.
    Silva IC; Lucena EA; Souza WO; Dantas AL; Dantas BM
    Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):37-40. PubMed ID: 20525457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99Mo/(99m)Tc separation: an assessment of technology options.
    Dash A; Knapp FF; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):167-76. PubMed ID: 23142410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radionuclide thyroid studies: a survey of practice in the United States in 1981. Special report.
    Parker TW; Mettler FA; Christie JH; Williams AG
    Radiology; 1984 Feb; 150(2):547-50. PubMed ID: 6318261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.